phlorhizin has been researched along with Acidosis, Diabetic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fralick, M; Kesselheim, AS | 1 |
| Rieg, T; Vallon, V | 1 |
1 review(s) available for phlorhizin and Acidosis, Diabetic
| Article | Year |
|---|---|
Development of SGLT1 and SGLT2 inhibitors.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Disease Models, Animal; Drug Design; Glucose; Humans; Intestinal Mucosa; Kidney; Mice; Mutation; Phlorhizin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
1 other study(ies) available for phlorhizin and Acidosis, Diabetic
| Article | Year |
|---|---|
Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis.
Topics: Clinical Trials as Topic; Data Collection; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Approval; Glycosides; Humans; Phlorhizin; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |